Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/REGENXBIO-INC-23733717/news/REGENXBIO-Inc-gibt-Lancet-Veroffentlichung-der-Phase-I-IIa-Studie-zur-Bewertung-von-ABBV-RGX-314-a-46310035/?utm_source=whatsapp&utm_medium=social&utm_campaign=share